Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-dose influenza vaccine for cardiovascular events after ACS
NCT04001504Phase 3Completed
- Sponsor
- Hospital Israelita Albert Einstein
- Start
- Jul 2019
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent influenza vaccine in influenza, acute coronary syndrome (ACS), sponsored by Hospital Israelita Albert Einstein. Started Jul 2019; status: completed.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenzaacute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04001504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04001504.